Suberoylanilide hydroxamic acid and 3-deazaneplocin a decrease lncRNA hox transcript antisense RNA in liver fibrosis

Özel, Merve

doi:10.14744/ijmb.2023.95914

Suberoylanilide hydroxamic acid and 3-deazaneplocin a decrease lncRNA hox transcript antisense RNA in liver fibrosis

Merve ÖZEL (Department of Biochemistry, Erciyes University Faculty of Medicine, Kayseri, Türkiye)

International Journal of Medical Biochemistry

1 0

Yıl: 2023 Cilt: 6 Sayı: 2 Sayfa Aralığı: 104 - 108 Metin Dili: İngilizce DOI: 10.14744/ijmb.2023.95914 İndeks Tarihi: 31-05-2023

Suberoylanilide hydroxamic acid and 3-deazaneplocin a decrease lncRNA hox transcript antisense RNA in liver fibrosis

Öz:

Objectives: Liver fibrosis stimulates the abnormal wound repair response of chronic tissue damage, leading to the emergence of many chronic liver diseases such as cirrhosis. In addition, this process is characterized by excessive accu- mulation of extracellular matrix (ECM) components. The activation of silent hepatic stellate cells (HSCs) in liver fibrosis leads to the release of more ECM. HOX transcript antisense RNA (HOTAIR) is a long non-coding RNAs (lncRNAs) that are overexpressed in numerous types of cancer and are also associated with a number of various fibrosis processes. Recent studies have shown that lncRNAs are important in epigenetic modification. In our study, we aimed to evaluate the effect of the epigenetic drugs suberoylanilide hydroxamic acid (SAHA) and 3-deazaneplanocin A (DZNep) on HOTAIR expression in HSC line (LX2). Methods: LX2 cells were scraped with TRIzol using a scraper and total RNAs were taken into ependorphs. After cDNA synthesis from RNA was obtained with the appropriate kit, cDNAs were amplified with FAM-labeled primer probes spe- cific to the mRNA sequence of the genes HOTAIR expression levels which were calculated 2(-ΔΔ)(CT) method and GAPDH was used for control gene. Results: Both SAHA and DZNep statistically decreased HOTAIR gene levels in LX2 cells (p<0.001; p<0.001, respectively). Conclusion: Due to the fact that both DZNep and SAHA reduced HOTAIR expression, it can be thought that the com- bined use of both drugs synergistically could be an important approach in preventing hepatic fibrosis. However, further mechanisms related to HOTAIR inhibition should be investigated in hepatic fibrosis. Keywords: DZNep, hepatic stellate cell, HOTAIR, SAHA

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005;115(2):209–18.
2. Lee UE, Friedman SL. Mechanisms of hepatic fibrogenesis. Best Pract Res Clin Gastroenterol 2011;25(2):195–06.
3. Peschansky V J, Wahlestedt C. Non-coding RNAs as direct and indirect modulators of epigenetic regulation. Epigenetics 2014;9:3–12.
4. Handy DE, Castro R, Loscalzo J. Epigenetic modifications: ba- sic mechanisms and role in cardiovascular disease. Circulation 2011;123(19):2145–56.
5. Zhang Y, Sun Z, Jia J, Du T, Zhang N, Tang Y, et al. Overview of histone modification. Adv Exp Med Biol 2021;1283:1–16.
6. Li Y, Seto E. HDACs and HDAC inhibitors in cancer devel- opment and therapy. Cold Spring Harb Perspect Med 2016;6(10):a026831.
7. Tang J, Yan H, Zhuang S. Histone deacetylases as tar- gets for treatment of multiple diseases. Clin Sci (Lond) 2013;124(11):651–62.
8. Mottamal M, Zheng S, Huang TL, Wang G. Histone deacetylase inhibitors in clinical studies as templates for new anticancer agents. Molecules 2015;20(3):3898–941.
9. Fiskus W, Wang Y, Sreekumar A, Buckley KM, Shi H, Jillella A, et al. Combined epigenetic therapy with the histone methyl- transferase EZH2 inhibitor 3-deazaneplanocin A and the his- tone deacetylase inhibitor panobinostat against human AML cells. Blood 2009;114(13):2733–43.
10. Jiang Y, Xiang C, Zhong F, Zhang Y, Wang L, Zhao Y, et al. His- tone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis. Theranostics 2021;11(1):361–78.
11. He Z, Yang D, Fan X, Zhang M, Li Y, Gu X, et al. the roles and mechanisms of lncRNAs in liver fibrosis. Int J Mol Sci 2020;21(4):1482.
12. Statello L, Guo CJ, Chen LL, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol 2021;22(2):96–118.
13. Bian EB, Wang YY, Yang Y, Wu BM, Xu T, Meng XM, et al. Ho - tair facilitates hepatic stellate cells activation and fibro- genesis in the liver. Biochim Biophys Acta Mol Basis Dis 2017;1863(3):674–86.
14. Özel M, Baskol M, Akalın H, Baskol G. Suberoylanilide hydrox- amic acid (SAHA) reduces fibrosis markers and deactivates human stellate cells via the epithelial-mesenchymal transition (EMT). Cell Biochem Biophys 2021;79(2):349–57.
15. Özel M, Güven İ, Kilic E, Dundar M, Baskol G. Enhancer of zeste homolog 2 (EZH2) gene inhibition via 3-Deazaneplanocin A (DZNep) in human liver cells and it is relation with fibrosis. Turk J Biochem 2020;45(6):737–45.
16. Cuevas-Diaz Duran R, Wei H, Kim DH, Wu JQ. Invited Review: Long non-coding RNAs: important regulators in the develop- ment, function and disorders of the central nervous system. Neuropathol Appl Neurobiol 2019;45(6):538–56.
17. El-Shendidi A, Ghazala R, Hassouna E. Circulating HOTAIR potentially predicts hepatocellular carcinoma in cirrhotic liver and prefigures the tumor stage. Clin Exp Hepatol 2022;8(2):139–46.
18. Zhou H, Gao L, Yu ZH, Hong SJ, Zhang ZW, Qiu ZZ. LncRNA HOTAIR promotes renal interstitial fibrosis by regulating Notch1 pathway via the modulation of miR-124. Nephrology (Carlton) 2019;24(4):472–80.
19. Tan W, Wang K, Yang X, Wang K, Wang N, Jiang TB. LncRNA HOTAIR promotes myocardial fibrosis in atrial fibrillation through binding with PTBP1 to increase the stability of Wn- t5a. Int J Cardiol 2022;369:21–28.
20. Ding R, Zheng J, Li N, Cheng Q, Zhu M, Wang Y, et al. DZNep, an inhibitor of the histone methyltransferase EZH2, suppresses hepatic fibrosis through regulating miR-199a-5p/SOCS7 path- way. PeerJ 2021;9:e11374.
21. Mimura I, Hirakawa Y, Kanki Y, Nakaki R, Suzuki Y, Tanaka T, et al. Genome-wide analysis revealed that DZNep reduces tubulointerstitial fibrosis via down-regulation of pro-fibrotic genes. Sci Rep 2018;8(1):3779.
22. Zhou X, Zang X, Ponnusamy M, Masucci MV, Tolbert E, Gong R, et al. Enhancer of zeste homolog 2 inhibition atenuates renal fibrosis by maintaining Smad7 and phos- phatase and tensin homolog expression. J Am Soc Nephrol 2016;27(7):2092–108.
23. Zeybel M, Luli S, Sabater L, Hardy T, Oakley F, Leslie J, et al. A proof-of-concept for epigenetic therapy of tissue fibrosis: inhibition of liver fibrosis progression by 3-deazaneplanocin A. Mol Ther 2017;25(1):218–31.
24. Li Y, Ren Y, Wang Y, Tan Y, Wang Q, Cai J, et al. A compound AC1Q3QWB selectively disrupts HOTAIR-mediated recruit- ment of PRC2 and enhances cancer therapy of DZNep. Thera- nostics 2019;9(16):4608–23.
25. Mayr C, Wagner A, Stoecklinger A, Jakab M, Illig R, Berr F, et al. 3-Deazaneplanocin A may directly target putative cancer stem cells in biliary tract cancer. Anticancer Res 2015;35(9):4697–705.
26. Strickertsson JAB, Grunnet M, Bardram L, Federspiel B, Friis- Hansen L. miR-449 and HDAC modulates HOTAIR expression which predicts poor prognosis in resected gastroesophageal adenocarcinomas and doubles proliferation rate in HFE145 cells. J Gastric Disord Ther 2017;3(2).
27. Ren Y, Jia HH, Xu YQ, Zhou X, Zhao XH, Wang YF, et al. Paracrine and epigenetic control of CAF-induced metastasis: The role of HOTAIR stimulated by TGF-ß1 secretion. Mol Cancer 2018;17:5.
28. Hibino S, Saito Y, Muramatsu T, Otani A, Kasai Y, Kimura M, et al. Inhibitors of enhancer of zeste homolog 2 (EZH2) activate tumor-suppressor microRNAs in human cancer cells. Oncoge- nesis 2014;3(5):e104.
29. Miranda TB, Cortez CC, Yoo CB, Liang G, Abe M, Kelly TK, et al. DZNep is a global histone methylation inhibitor that reacti- vates developmental genes not silenced by DNA methylation. Mol Cancer Ther 2009;8(6):1579–88.

APA	Özel M (2023). Suberoylanilide hydroxamic acid and 3-deazaneplocin a decrease lncRNA hox transcript antisense RNA in liver fibrosis. , 104 - 108. 10.14744/ijmb.2023.95914
Chicago	Özel Merve Suberoylanilide hydroxamic acid and 3-deazaneplocin a decrease lncRNA hox transcript antisense RNA in liver fibrosis. (2023): 104 - 108. 10.14744/ijmb.2023.95914
MLA	Özel Merve Suberoylanilide hydroxamic acid and 3-deazaneplocin a decrease lncRNA hox transcript antisense RNA in liver fibrosis. , 2023, ss.104 - 108. 10.14744/ijmb.2023.95914
AMA	Özel M Suberoylanilide hydroxamic acid and 3-deazaneplocin a decrease lncRNA hox transcript antisense RNA in liver fibrosis. . 2023; 104 - 108. 10.14744/ijmb.2023.95914
Vancouver	Özel M Suberoylanilide hydroxamic acid and 3-deazaneplocin a decrease lncRNA hox transcript antisense RNA in liver fibrosis. . 2023; 104 - 108. 10.14744/ijmb.2023.95914
IEEE	Özel M "Suberoylanilide hydroxamic acid and 3-deazaneplocin a decrease lncRNA hox transcript antisense RNA in liver fibrosis." , ss.104 - 108, 2023. 10.14744/ijmb.2023.95914
ISNAD	Özel, Merve. "Suberoylanilide hydroxamic acid and 3-deazaneplocin a decrease lncRNA hox transcript antisense RNA in liver fibrosis". (2023), 104-108. https://doi.org/10.14744/ijmb.2023.95914

APA	Özel M (2023). Suberoylanilide hydroxamic acid and 3-deazaneplocin a decrease lncRNA hox transcript antisense RNA in liver fibrosis. International Journal of Medical Biochemistry, 6(2), 104 - 108. 10.14744/ijmb.2023.95914
Chicago	Özel Merve Suberoylanilide hydroxamic acid and 3-deazaneplocin a decrease lncRNA hox transcript antisense RNA in liver fibrosis. International Journal of Medical Biochemistry 6, no.2 (2023): 104 - 108. 10.14744/ijmb.2023.95914
MLA	Özel Merve Suberoylanilide hydroxamic acid and 3-deazaneplocin a decrease lncRNA hox transcript antisense RNA in liver fibrosis. International Journal of Medical Biochemistry, vol.6, no.2, 2023, ss.104 - 108. 10.14744/ijmb.2023.95914
AMA	Özel M Suberoylanilide hydroxamic acid and 3-deazaneplocin a decrease lncRNA hox transcript antisense RNA in liver fibrosis. International Journal of Medical Biochemistry. 2023; 6(2): 104 - 108. 10.14744/ijmb.2023.95914
Vancouver	Özel M Suberoylanilide hydroxamic acid and 3-deazaneplocin a decrease lncRNA hox transcript antisense RNA in liver fibrosis. International Journal of Medical Biochemistry. 2023; 6(2): 104 - 108. 10.14744/ijmb.2023.95914
IEEE	Özel M "Suberoylanilide hydroxamic acid and 3-deazaneplocin a decrease lncRNA hox transcript antisense RNA in liver fibrosis." International Journal of Medical Biochemistry, 6, ss.104 - 108, 2023. 10.14744/ijmb.2023.95914
ISNAD	Özel, Merve. "Suberoylanilide hydroxamic acid and 3-deazaneplocin a decrease lncRNA hox transcript antisense RNA in liver fibrosis". International Journal of Medical Biochemistry 6/2 (2023), 104-108. https://doi.org/10.14744/ijmb.2023.95914